Classic psychedelics, such as psilocybin, mescaline, LSD, and DMT, profoundly impact perception, cognition, and emotion, often resulting in deeply meaningful and transformative experiences (Griffiths et al., 2006; Nichols, 2016). Several studies have shown that classic psychedelics are effective for treating a range of mood and substance use disorders under supportive conditions (Griffiths et al., 2016; Davis et al., 2021, 2023; Bogenschutz et al., 2022). Evidence indicates that these therapeutic effects can be long-lasting, providing sustained clinical relief for months or even years (Aday et al., 2020; Agin-Liebes et al., 2020). Agonism at 5-HT2A receptors is thought to be primarily responsible for their subjective effects (Preller et al., 2017; Stenbæk et al., 2021), although the mechanism of action in clinical studies is not fully understood. While neurobiological mechanisms are undoubtedly crucial, they alone may not fully account for enduring beneficial effects (Yaden and Griffiths, 2021). The effects of psychedelics are highly dependent on contextual variables, including the environment and mindset of the individual, often referred to as “set and setting” (Eisner, 1997; Hartogsohn, 2016; Carhart-Harris et al., 2018). This sensitivity to context suggests that the psychological and experiential dimensions play a critical role in shaping the outcomes of the psychedelic experience.

One such factor that remains understudied is the aesthetic quality of the psychedelic experience. The aesthetic experience is a complex emergent phenomenon that occurs as a result of the dynamic interplay between sensory perception, emotional valuation, and cognitive interpretation, mediated by distributed neural networks, including the default mode network (DMN), salience network, and visual processing regions, which together shape meaning-making, psychological insight, and subjective appreciation of beauty (Chatterjee and Vartanian, 2014; Pearce et al., 2016; Belfi et al., 2019). Aesthetic experiences play a significant role in evoking emotional responses and facilitating shifts in cognition and behavior (Mastandrea et al., 2019). Psychedelic substances are well-documented for their ability to enhance sensory and emotional sensitivity, leading to characteristic hallucinations and deeply felt emotional responses. Some of these responses can be seen in psychedelic art, indicating that psychedelics might possess their own aesthetic (Krippner, 2017). Induced aesthetic enhancements—ranging from intensified colors and patterns to the perception of symbolic imagery—engage distributed neural networks related to perceptual and semantic regulation, such as the DMN, and may facilitate emotional breakthroughs (Carhart-Harris et al., 2012; Kaelen et al., 2015; Pasquini et al., 2020). Changes in sensory, cognitive, and emotional processes during altered states contribute to profound psychological shifts, often resulting in lasting therapeutic outcomes, such as greater psychological flexibility and reduced symptoms of anxiety and depression (Roseman et al., 2019; Barrett et al., 2020). However, it remains unclear whether the perceived aesthetic quality of these experiences directly contributes to the positive psychological outcomes frequently reported by recreational users and in clinical studies.

Beyond their impact on individual perception, aesthetic experiences induced by psychedelics may play a role in broader cognitive and existential frameworks, shaping how individuals interpret and integrate their experiences. Previous research has linked peak experiences—including those marked by intense beauty, awe, and transcendence—to long-term shifts in personality traits such as openness and well-being (MacLean et al., 2011; Majić et al., 2015). Similarly, profound aesthetic alterations reported under psychedelics might function as a catalyst for meaning-making, where visually and emotionally salient stimuli trigger insight, emotional breakthroughs, metaphysical beliefs, and an expanded sense of self (Kettner et al., 2021; Timmermann et al., 2021). Thus, aesthetic perception under altered states of consciousness could represent an important mechanism through which psychedelics facilitate broad psychological change.

Given this, the current study aimed to explore how aesthetic qualities influence both positive and negative aspects of the psychedelic experience, particularly those linked to long-term outcomes for depression and anxiety (Peill et al., 2022). Using a web-based survey, participants reported exclusively on their most ‘typical’ psychedelic experience, evaluating aesthetic quality, positive emotions (e.g., emotional breakthroughs, psychological insight), negative emotions (e.g., distress, fear, paranoia), and related outcomes such as changes in depression and anxiety. We hypothesized that higher aesthetic pleasure would be associated with positive psychological outcomes, while negative aesthetic experiences would be associated with challenging experiences and worse psychological outcomes. We examine the connection between psychedelic-induced aesthetics and emotional responses and aim to contribute to the understanding of how psychedelics generate lasting psychological benefits, with potential implications for therapeutic applications.

The present study adds to our understanding of how psychedelic experiences may contribute to positive psychological outcomes. While previous research has emphasized the significance of mystical and emotional breakthroughs (Barrett et al., 2015; Griffiths et al., 2018; Roseman et al., 2019), less attention has been given to the role of aesthetic components. Our findings suggest that psychedelic induced aesthetic enhancements are more than mere perceptual oddities, they appear to promote emotional engagement and cognitive shifts that may lead to enduring psychological benefits.

The correlation between aesthetic experience and psychological insight suggests that aesthetics may play a meaningful role in the therapeutic effects of psychedelics. The significant associations among mystical experiences, emotional breakthroughs, and aesthetic experiences further support the idea that, while these constructs are distinct, they contribute to overlapping psychological processes that are relevant for therapeutic outcomes. Notably, aesthetic experience was significantly correlated with improvements in psychological well-being. We found positive associations with improved quality of life, anxiety, and depression, even when controlling for potential confounders. These findings suggest that aesthetic engagement during psychedelic experiences may facilitate emotional and cognitive shifts, directly or indirectly impacting well-being. Future research utilizing pathway analysis or structural equation modeling (SEM) could help determine these relationships, clarifying the mechanisms through which aesthetic experience contributes to psychological effects and refining predictive models for therapeutic efficacy.

Another important finding is the relationship between challenging experiences, as measured by the CEQ, and aesthetic quality. Challenging experiences, such as fear and paranoia, are negatively correlated with positive psychological outcomes (Barrett et al., 2016). Likewise, we found that aesthetic experiences are inversely related to challenging experiences, indicating that when participants reported lower aesthetic quality, they were more likely to also encounter difficult emotional states. This relationship is particularly relevant for psychedelic-assisted therapy (PAT), as it suggests that enhancing the aesthetic environment could mitigate the intensity of challenging emotions, potentially leading to better therapeutic outcomes. Better understanding this dynamic could help optimize therapeutic protocols to create settings that promote positive emotional engagement while reducing the likelihood of adverse events.

Aesthetic experience is an emergent phenomenon arising from the integration of sensory-motor, emotion-valuation, and meaning-knowledge neural systems (Chatterjee and Vartanian, 2014), and it is studied empirically within the field of neuroaesthetics (Pearce et al., 2016). This framework suggests that aesthetic experience extends beyond passive sensory evaluation, engaging deeper affective and semantic processes. Notably, there is substantial evidence indicating that the reflective component of aesthetic experience is linked to the dynamics of DMN activity (Vessel et al., 2012, 2013, 2019; Belfi et al., 2019). A compelling parallel exists in the psychedelic literature, where DMN activity is consistently implicated, particularly in relation to the phenomenon of ‘ego death,’ which involves a dissolution of self-boundaries and heightened integration across neural systems (Carhart-Harris and Friston, 2010; Nour et al., 2016; Stoliker et al., 2022). This parallel, along with our data, presents a promising vein of research for future investigation utilizing advanced neuroimaging techniques.

Our findings, though cross-sectional, offer additional perspective on the mechanisms through which psychedelics exert their therapeutic effects. Future research could investigate whether manipulating the aesthetic environment during psychedelic sessions—such as through visual art, music, or immersive settings—might enhance the therapeutic process. Furthermore, longitudinal studies would be valuable in determining whether the lasting psychological benefits attributed to aesthetic experiences are maintained over time and whether specific aesthetic qualities are more effective than others in aiding psychological growth. Relatedly, (Aday et al., 2024) found that participants in a naturalistic ayahuasca study exhibited increased levels of aesthetic appreciation at both the 1-week and 1-month follow-ups.

This study has several limitations. First, its cross-sectional design prevents causal inference between psychedelic-induced aesthetic experiences and psychological outcomes. While significant associations were observed, it remains unclear whether enhanced aesthetics improve psychological well-being or if individuals with greater psychological openness report heightened aesthetic experiences. Longitudinal studies are needed to determine directionality.

Second, reliance on self-reported data introduces biases, including recall bias, social desirability, and expectancy effects. Participants may have exaggerated or minimized aspects of their experiences, influenced by cultural or personal expectations. Future research should integrate objective measures, such as psychophysiological responses or real-time experience sampling, to complement self-report data.

Third, the sample size (n = 96) was relatively small and recruited via social media and snowball sampling, introducing selection bias. Participants may have been more positively inclined toward psychedelics or had particularly salient aesthetic experiences. Additionally, the demographic composition limits generalizability. Future studies should recruit larger, more diverse samples to assess whether these effects extend across populations.

Fourth, the single-item measure of aesthetic experience (PAEQ-S), while practical, lacks granularity. The full 21-item PAEQ was excluded due to lack of prior validation, leading to a broad but potentially oversimplified assessment. This is particularly relevant for negative aesthetic experiences, which may differ qualitatively from positive ones. Additionally, single-item measures introduce ambiguity, as a “strongly disagree” response could reflect either a neutral or aversive experience. A forthcoming study will refine and validate the full PAEQ with a larger dataset.

Finally, while our analyses controlled for key demographic factors, unmeasured confounders remain. Variables such as set and setting, prior psychedelic use, dose, and pre-existing mental health conditions were not explicitly accounted for but may have influenced outcomes. Future research should systematically address these factors. Despite these limitations, this study offers a novel exploration of psychedelic-induced aesthetic experiences and their psychological implications. Addressing these methodological challenges will help clarify underlying mechanisms and therapeutic potential.

This study demonstrates that the aesthetic quality of psychedelic experiences may be a crucial factor in predicting positive psychological outcomes, corroborating claims that subjective experience is necessary for psychedelic-induced therapeutic effects. By enhancing perceptual and emotional sensitivity, psychedelics create an aesthetic experience that may contribute to psychological insight and emotional breakthroughs, offering a novel mechanism for understanding their therapeutic potential. Understanding how these experiences operate provides a more comprehensive framework for the use of psychedelics in therapeutic settings, potentially informing clinical protocols that integrate aesthetic elements to maximize psychological benefit.